Healthcare provider profile · identity verified

Isabelle Nawaz, MD

Family Practice · PHILADELPHIA, PA · NPI 1306374384

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	606	189
Amlodipine Besylate	Amlodipine Besylate	575	163
Losartan Potassium	Losartan Potassium	322	96
Metformin Hcl	Metformin Hcl	243	72
Hydrochlorothiazide	Hydrochlorothiazide	197	62
Nifedipine Er	Nifedipine	192	65
Albuterol Sulfate Hfa	Albuterol Sulfate	175	44
Lisinopril	Lisinopril	168	50
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	164	48
Metoprolol Succinate	Metoprolol Succinate	160	51
Levothyroxine Sodium	Levothyroxine Sodium	157	42
Gabapentin	Gabapentin	152	49
Furosemide	Furosemide	142	47
Pantoprazole Sodium	Pantoprazole Sodium	132	35
Carvedilol	Carvedilol	103	35
Rosuvastatin Calcium	Rosuvastatin Calcium	101	33
Metoprolol Tartrate	Metoprolol Tartrate	93	32
Omeprazole	Omeprazole	85	29
Eliquis	Apixaban	82	21
Potassium Chloride	Potassium Chloride	75	24
Fluticasone Propionate	Fluticasone Propionate	74	32
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	73	22
Ozempic	Semaglutide	72	25
Simvastatin	Simvastatin	69	23
Ibuprofen	Ibuprofen	68	23
Famotidine	Famotidine	66	28
Tamsulosin Hcl	Tamsulosin Hcl	66	21
Oxycodone Hcl	Oxycodone Hcl	64	18
Prednisone	Prednisone	61	40
Trazodone Hcl	Trazodone Hcl	61	17
Chlorthalidone	Chlorthalidone	57	18
Januvia	Sitagliptin Phosphate	57	15
Clopidogrel	Clopidogrel Bisulfate	56	15
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	55	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	55	16
Pravastatin Sodium	Pravastatin Sodium	53	24
Hydralazine Hcl	Hydralazine Hcl	52	17
Mirtazapine	Mirtazapine	52	20
Mounjaro	Tirzepatide	50	13
Lovastatin	Lovastatin	48	14
Glimepiride	Glimepiride	47	11
Levetiracetam	Levetiracetam	46	11
Sertraline Hcl	Sertraline Hcl	46	14
Montelukast Sodium	Montelukast Sodium	42	14
Glipizide	Glipizide	41	14
Pregabalin	Pregabalin	41	13
Allopurinol	Allopurinol	40	15
Farxiga	Dapagliflozin Propanediol	40	13
Finasteride	Finasteride	40	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	39	12
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	39	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	39	13
Ezetimibe	Ezetimibe	36	11
Baclofen	Baclofen	35	18
Duloxetine Hcl	Duloxetine Hcl	35	12
Metformin Hcl Er	Metformin Hcl	35	12
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	33	11
Tramadol Hcl	Tramadol Hcl	33	suppressed
Alendronate Sodium	Alendronate Sodium	30	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	30	13
Glipizide Er	Glipizide	30	12
Oxybutynin Chloride	Oxybutynin Chloride	30	suppressed
Arnuity Ellipta	Fluticasone Furoate	28	suppressed
Donepezil Hcl	Donepezil Hcl	27	suppressed
Humalog Kwikpen U-100	Insulin Lispro	27	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Lorazepam	Lorazepam	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Diclofenac Sodium	Diclofenac Sodium	25	11
Amoxicillin	Amoxicillin	24	18
Benazepril Hcl	Benazepril Hcl	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	24	suppressed
Bumetanide	Bumetanide	24	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	suppressed
Tizanidine Hcl	Tizanidine Hcl	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	16
Warfarin Sodium	Warfarin Sodium	22	suppressed
Enalapril Maleate	Enalapril Maleate	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Atenolol	Atenolol	20	suppressed
Azelastine Hcl	Azelastine Hcl	20	suppressed
Breo Ellipta	Fluticasone/Vilanterol	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Synthroid	Levothyroxine Sodium	20	suppressed
Alprazolam	Alprazolam	19	suppressed
Irbesartan	Irbesartan	19	suppressed
Valsartan	Valsartan	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Jardiance	Empagliflozin	18	suppressed
Klor-Con M20	Potassium Chloride	18	suppressed
Xarelto	Rivaroxaban	18	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	17	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	17	suppressed
Meloxicam	Meloxicam	17	suppressed
Nystatin	Nystatin	16	suppressed
Celecoxib	Celecoxib	15	suppressed
Citalopram Hbr	Citalopram Hydrobromide	15	suppressed
Colchicine	Colchicine	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	13	suppressed
Azithromycin	Azithromycin	12	12
Labetalol Hcl	Labetalol Hcl	12	suppressed
Levetiracetam Er	Levetiracetam	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Cilostazol	Cilostazol	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Naproxen	Naproxen	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error